Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.0084 | 0.9 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0022 | 0.9 |
mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.011 | 1 |
mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0025 | 1 |